Vancouver’s Bio Conscious Technologies has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future.
This is a huge improvement on industry-leading continuous glucose monitoring (CGM) companies that offer only 20-minute predictions.
Diabits is an artificial intelligence-powered diabetes management app for people with type I and type II diabetes who use a CGM to monitor their daily blood sugar fluctuations.
“The ability to accurately predict glucose levels with the Diabits app helps users improve blood sugar management by increasing the time that they have to react. This enables proactive management of highs and lows to help them stay within a healthy glucose range for a longer time during the day and ultimately keep them healthier,” said Amir Hayeri, CEO of Bio Conscious.
“Additionally this information could be transmitted to a pump or a smart insulin pen to calculate the precise amount of insulin needed and the optimal time for injection. This can further minimize fluctuations and excursions beyond recommended glucose range.”
Maintaining daily blood sugar is imperative to maintaining the strength of the immune system.
A new French study has showed that 35.5% of those who died from COVID-19 had Diabetes. The International Diabetes Federation reported that when people with diabetes develop a viral infection, it can be harder to treat due to fluctuations in blood glucose levels.